Company Sienna Biopharmaceuticals, Inc.
Equities
SNNAQ
US82622H1086
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% |
|
-.--% | -.--% |
Business Summary
Number of employees: 13
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 10-06-26 | |
Majed Kheir
COO | Chief Operating Officer | 46 | 15-12-31 |
Silvio Traversa
CTO | Chief Tech/Sci/R&D Officer | 54 | 16-11-30 |
Sean P. Andrews
IRC | Investor Relations Contact | - | - |
General Counsel | 45 | 16-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 59 | 10-06-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,050,542 | 30,907,542 ( 99.54 %) | 143,000 ( 0.4605 %) | 99.54 % |
Company contact information
Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road Suite 140
91362, Westlake Village
+
![address Sienna Biopharmaceuticals, Inc.(SNNAQ)](https://cdn.zonebourse.com/static/address/120796677.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 22 | |
+15.58% | 122B | |
+16.60% | 113B | |
+17.55% | 26.22B | |
-24.33% | 19.01B | |
-19.14% | 15.71B | |
-17.95% | 15.22B | |
-46.81% | 14.72B | |
+58.78% | 14.58B | |
+4.91% | 13.84B |
- Stock Market
- Equities
- SNNAQ Stock
- Company Sienna Biopharmaceuticals, Inc.